title: PET, PET/CT, and PET/MR Imaging Assessment of Breast Cancer.
abstract: This review focuses mainly on clinical applications of PET/CT in patients with breast cancer. It discusses the role of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) PET/CT (and FDG PET) in the diagnosis and initial staging of breast cancer, in monitoring the response of disease to chemotherapy, and in identifying metastatic and recurrent disease. In addition, it discusses the role of MR imaging and potential future hybrid modalities such as PET/MR imaging.
authors.affiliation: Department of Nuclear Medicine, All India Institute of Medical Sciences, E-81, Ansari Nagar (East), AIIMS Campus, New Delhi 110029, India.
authors.forename: Shamim
authors.initials: S
authors.lastname: Ahmed Shamim
authors.affiliation: Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
authors.forename: Drew A
authors.initials: DA
authors.lastname: Torigian
authors.affiliation: Department of Nuclear Medicine, All India Institute of Medical Sciences, E-81, Ansari Nagar (East), AIIMS Campus, New Delhi 110029, India. Electronic address: rkphulia@yahoo.com.
authors.forename: Rakesh
authors.initials: R
authors.lastname: Kumar
keywords: Breast cancer; Computed tomography (CT); Magnetic resonance imaging (MRI); Oncology; PET mammography; PET/CT; PET/MRI; Positron emission tomography (PET)